Read + Share
Tsumura Y, Tsushima Y, Tamura A, Kato H, et al. Disruptions in hepatic glucose metabolism are involved in the diminished efficacy
after chronic treatment with glucokinase activator. PLoS One 2022;17:e0265761.
PMID: 35312718
|
 |
|
Tsumura Y, Tsushima Y, Tamura A, Kato H, et al. Disruptions in hepatic glucose metabolism are involved in the diminished efficacy
after chronic treatment with glucokinase activator. PLoS One 2022;17:e0265761.
PMID: 35312718
|
|
|
|